ID

36382

Description

Study ID: 109609 Clinical Study ID: 109609 Study Title: A Phase II, Non-randomized, Multi-center Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) in Subjects With Advanced Non-Small Cell Lung Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00549328 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: GW786034 Trade Name: Drug: Pazopanib Study Indication: Lung Cancer, Non-Small Cell

Keywords

  1. 5/8/19 5/8/19 -
  2. 8/14/19 8/14/19 -
  3. 8/14/19 8/14/19 -
  4. 3/15/21 3/15/21 - Dr. rer. medic Philipp Neuhaus
Copyright Holder

GlaxoSmithKline

Uploaded on

May 8, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Efficacy and Safety of Pazopanib (GW786034) in Subjects With Advanced Non-Small Cell Lung Cancer NCT00549328

Screening - Subject Identification; Demography; Eligibility Question; Disease Characteristics; Status at Screening; Anti-Cancer Therapy; Anti-Cancer Radiotherapy; Medical Conditions

Inform Screening
Description

Inform Screening

Alias
UMLS CUI-1
C1710477
Subject initials
Description

Subject initials

Data type

integer

Alias
UMLS CUI [1,1]
C1997894
UMLS CUI [1,2]
C2986440
Date of birth
Description

Date of birth

Data type

date

What is the primary method that prompted the subject's interest in the study?
Description

What is the primary method that prompted the subject's interest in the study?

Data type

integer

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0543488
UMLS CUI [1,3]
C0392360
If other Internet provider paid by GSK. (e.g., harrisinteractive.com), specify
Description

If other Internet provider paid by GSK. (e.g., harrisinteractive.com), specify

Data type

text

Alias
UMLS CUI [1,1]
C1138603
UMLS CUI [1,2]
C0205394
If other primary method that prompted the subject's interest in the study, please specify.
Description

If other primary method that prompted the subject's interest in the study, please specify.

Data type

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0543488
UMLS CUI [1,3]
C0392360
UMLS CUI [1,4]
C0205394
UMLS CUI [1,5]
C2348235
Was this subject a screen failure?
Description

Was this subject a screen failure?

Data type

integer

Alias
UMLS CUI [1]
C1710476
Subject number
Description

Subject number

Alias
UMLS CUI-1
C2348585
Subject number
Description

Subject number

Data type

integer

Alias
UMLS CUI [1]
C2348585
Date of Visit/ Assessment
Description

Date of Visit/ Assessment

Alias
UMLS CUI-1
C1320303
UMLS CUI-2
C2985720
Date of Visit/ Assessment
Description

Date of Visit/ Assessment

Data type

date

Alias
UMLS CUI [1,1]
C1320303
UMLS CUI [1,2]
C2985720
Local Laboratories
Description

Local Laboratories

Alias
UMLS CUI-1
C0022877
UMLS CUI-2
C0205276
Select the number of local laboratories used by the subject during the study.
Description

If another local laboratory is used after you have already selected a response and submitted fjjjl Th the form, change your response and an additional local laboratory form will be created.

Data type

integer

Alias
UMLS CUI [1,1]
C0022877
UMLS CUI [1,2]
C0205276
UMLS CUI [1,3]
C0237753
Laboratory Name
Description

Laboratory Name

Data type

text

Alias
UMLS CUI [1]
C3258037
Laboratory Address
Description

Laboratory Address

Data type

text

Alias
UMLS CUI [1,1]
C1442065
UMLS CUI [1,2]
C0022877
Laboratory ID
Description

Laboratory ID

Data type

text

Alias
UMLS CUI [1]
C2986056
Subject identification
Description

Subject identification

Alias
UMLS CUI-1
C2348585
Subject number
Description

Subject number

Data type

text

Alias
UMLS CUI [1]
C2348585
Demography
Description

Demography

Alias
UMLS CUI-1
C0011298
Date of birth
Description

Date of birth

Data type

date

Alias
UMLS CUI [1]
C0421451
Sex
Description

Sex

Data type

text

Alias
UMLS CUI [1]
C0079399
Ethnicity
Description

Ethnicity

Data type

integer

Alias
UMLS CUI [1]
C0015031
Geographic Ancestry
Description

Check all that apply

Data type

integer

Alias
UMLS CUI [1]
C3841890
Eligibility Question
Description

Eligibility Question

Alias
UMLS CUI-1
C1516637
Did the subject meet all the entry criteria?
Description

Did the subject meet all the entry criteria?

Data type

boolean

Alias
UMLS CUI [1]
C1516637
If subject did not meet all the entry criteria, please select all boxes corresponding to violations of any inclusion/exclusion criteria
Description

Select all boxes corresponding to violations of any inclusion/exclusion criteria

Data type

integer

Alias
UMLS CUI [1]
C1516637
Disease Characteristics
Description

Disease Characteristics

Alias
UMLS CUI-1
C1705348
Primary Tumour Type at Initial Diagnosis
Description

Primary Tumour Type at Initial Diagnosis

Data type

integer

Alias
UMLS CUI [1,1]
C0677930
UMLS CUI [1,2]
C0332307
UMLS CUI [1,3]
C4071762
Date of Initial Diagnosis
Description

Date of Initial Diagnosis

Data type

date

Alias
UMLS CUI [1]
C2316983
Stage at Initial Diagnosis
Description

Stage at Initial Diagnosis

Data type

integer

Alias
UMLS CUI [1,1]
C1300072
UMLS CUI [1,2]
C0011900
UMLS CUI [1,3]
C0205265
Histology at Initial Diagnosis
Description

Histology at Initial Diagnosis

Data type

integer

Alias
UMLS CUI [1,1]
C0019638
UMLS CUI [1,2]
C0011900
UMLS CUI [1,3]
C0205265
Date of Last Progression
Description

Date of Last Progression

Data type

date

Alias
UMLS CUI [1,1]
C0242656
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C1517741
Date of Staging at Screening
Description

Date of Staging at Screening

Data type

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0027646
UMLS CUI [2]
C1710477
Stage at Screening
Description

Stage at Screening

Data type

integer

Alias
UMLS CUI [1,1]
C1300072
UMLS CUI [1,2]
C0220908
Lines of Therapy Completed at Screening
Description

Lines of Therapy Completed at Screening

Data type

integer

Alias
UMLS CUI [1]
C1514463
Metastatic Disease
Description

Metastatic Disease

Alias
UMLS CUI-1
C0027627
Did the subject have metastatic disease at screening?
Description

Did the subject have metastatic disease at screening?

Data type

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0220908
If subject had metastatic disease at screening, complete date metastatic disease was first diagnosed
Description

If subject had metastatic disease at screening, complete date metastatic disease was first diagnosed

Data type

date

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0220908
UMLS CUI [1,3]
C0011008
Status at Screening
Description

Status at Screening

Alias
UMLS CUI-1
C0220908
UMLS CUI-2
C0449438
Did the subject receive prior chemo, immuno, hormonal or biologic therapies for the cancer under study?
Description

Did the subject receive prior chemo, immuno, hormonal or biologic therapies for the cancer under study?

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0920425
UMLS CUI [1,3]
C0332152
UMLS CUI [2,1]
C0279025
UMLS CUI [2,2]
C0920425
UMLS CUI [2,3]
C0332152
UMLS CUI [3,1]
C1531518
UMLS CUI [3,2]
C0920425
UMLS CUI [3,3]
C0332152
UMLS CUI [4,1]
C0021083
UMLS CUI [4,2]
C0920425
UMLS CUI [4,3]
C0332152
Did the subject receive prior radiotherapy for the cancer under study?
Description

Did the subject receive prior radiotherapy for the cancer under study?

Data type

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0920425
UMLS CUI [1,3]
C0332152
Has subject had prior surgery/ procedure?
Description

Has subject had prior surgery/ procedure?

Data type

boolean

Alias
UMLS CUI [1]
C0744961
Were any concomitant medications taken by the subject prior to screening?
Description

Were any concomitant medications taken by the subject prior to screening?

Data type

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C0220908
Anti-Cancer Therapy
Description

Anti-Cancer Therapy

Alias
UMLS CUI-1
C0920425
Sequence Number
Description

Sequence Number

Data type

integer

Alias
UMLS CUI [1]
C2348184
Drug Name
Description

(Trade Name preferred)

Data type

text

Alias
UMLS CUI [1]
C0013227
Modified reported term
Description

Modified reported term

Data type

text

Alias
UMLS CUI [1]
C2826302
GSK Drug synonym
Description

GSK Drug synonym

Data type

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0871468
GSR Drug Collection code
Description

GSR Drug Collection code

Data type

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1516698
UMLS CUI [1,3]
C0805701
Failed coding
Description

Failed coding

Data type

text

Alias
UMLS CUI [1,1]
C0805701
UMLS CUI [1,2]
C0231175
Regimen Sequence
Description

Regimen Sequence

Data type

integer

Alias
UMLS CUI [1,1]
C1276413
UMLS CUI [1,2]
C2348184
Therapy Type
Description

Therapy Type

Data type

integer

Alias
UMLS CUI [1,1]
C0332307
UMLS CUI [1,2]
C0087111
Number of Cycles/Doses
Description

Number of Cycles/Doses

Data type

integer

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0750480
Units
Description

Units

Data type

integer

Alias
UMLS CUI [1]
C1519795
Intent
Description

Intent

Data type

integer

Alias
UMLS CUI [1]
C1283828
Therapy Start Date
Description

Therapy Start Date

Data type

date

Alias
UMLS CUI [1]
C1531783
Therapy Stop Date
Description

Therapy Stop Date

Data type

date

Alias
UMLS CUI [1]
C1531784
Best Response
Description

Best Response

Data type

integer

Alias
UMLS CUI [1]
C2986560
Duration of Response
Description

Duration of Response

Data type

durationDatetime

Measurement units
  • Weeks
Alias
UMLS CUI [1]
C0237585
Weeks
Anti-Cancer Therapy
Description

Anti-Cancer Therapy

Alias
UMLS CUI-1
C0920425
Sequence Number
Description

Sequence Number

Data type

integer

Alias
UMLS CUI [1]
C2348184
Site
Description

Site

Data type

text

Alias
UMLS CUI [1]
C2825164
Cumulative Dose
Description

Cumulative Dose

Data type

float

Alias
UMLS CUI [1]
C2986497
Units
Description

Units

Data type

integer

Alias
UMLS CUI [1]
C1519795
Intent
Description

Intent

Data type

integer

Alias
UMLS CUI [1]
C1283828
Radiotherapy Start Date
Description

Radiotherapy Start Date

Data type

date

Alias
UMLS CUI [1]
C0436382
Radiotherapy Stop Date
Description

Radiotherapy Stop Date

Data type

date

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0806020
Best Response
Description

Best Response

Data type

integer

Alias
UMLS CUI [1]
C2986560
Duration of Response
Description

Duration of Response

Data type

durationDatetime

Measurement units
  • Weeks
Alias
UMLS CUI [1]
C0237585
Weeks
Medical Conditions
Description

Medical Conditions

Alias
UMLS CUI-1
C0012634
Sequence Number
Description

Sequence Number

Data type

integer

Alias
UMLS CUI [1]
C2348184
Specific Condition
Description

Specific Condition

Data type

text

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C2348235
Modified Term
Description

Modified Term

Data type

text

Alias
UMLS CUI [1]
C2826302
MedDRA Synonym
Description

MedDRA Synonym

Data type

text

Alias
UMLS CUI [1]
C1140263
MedDRA lower level term code
Description

MedDRA lower level term code

Data type

text

Alias
UMLS CUI [1]
C3898442
Failed coding
Description

Failed coding

Data type

text

Alias
UMLS CUI [1,1]
C0805701
UMLS CUI [1,2]
C0231175
NCI CTCAE v.3 Grade
Description

NCI CTCAE v.3 Grade

Data type

integer

Alias
UMLS CUI [1]
C3887242
Status
Description

Status

Data type

integer

Alias
UMLS CUI [1]
C0449438
Classification
Description

Classification

Data type

integer

Alias
UMLS CUI [1]
C0008902

Similar models

Screening - Subject Identification; Demography; Eligibility Question; Disease Characteristics; Status at Screening; Anti-Cancer Therapy; Anti-Cancer Radiotherapy; Medical Conditions

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inform Screening
C1710477 (UMLS CUI-1)
Subject initials
Item
Subject initials
integer
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
Date of birth
Item
Date of birth
date
Item
What is the primary method that prompted the subject's interest in the study?
integer
C0008976 (UMLS CUI [1,1])
C0543488 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Code List
What is the primary method that prompted the subject's interest in the study?
CL Item
Clinic patient (site actively reviews patient charts and/or databases and initiates contact with patient). (1)
CL Item
Physician referral (e.g., lunch-n—learn, letter to colleagues, etc.) (2)
CL Item
Referred by family member (3)
CL Item
Referred by study participant (4)
CL Item
Subject-initiated internet search (e.g. discovered findclinicalstudy.com) (5)
CL Item
Other Internet provider paid by GSK. (e.g., harrisinteractive.com), specify (6)
CL Item
Information in clinic (e.g., posters, brochure, etc.) (7)
CL Item
Community outreach (e.g., healthfair, advocacy groups, support groups, etc.) (8)
CL Item
Local newspaper advertisement (9)
CL Item
Local radio advertisement (10)
CL Item
Other local paid advertisement (e.g., local television, local direct mail, etc.) (11)
CL Item
Other, specify (12)
If other Internet provider paid by GSK. (e.g., harrisinteractive.com), specify
Item
If other Internet provider paid by GSK. (e.g., harrisinteractive.com), specify
text
C1138603 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
If other primary method that prompted the subject's interest in the study, please specify.
Item
If other primary method that prompted the subject's interest in the study, please specify.
text
C0008976 (UMLS CUI [1,1])
C0543488 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])
Item
Was this subject a screen failure?
integer
C1710476 (UMLS CUI [1])
Code List
Was this subject a screen failure?
CL Item
No (1)
Item Group
Subject number
C2348585 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Item Group
Date of Visit/ Assessment
C1320303 (UMLS CUI-1)
C2985720 (UMLS CUI-2)
Date of Visit/ Assessment
Item
Date of Visit/ Assessment
date
C1320303 (UMLS CUI [1,1])
C2985720 (UMLS CUI [1,2])
Item Group
Local Laboratories
C0022877 (UMLS CUI-1)
C0205276 (UMLS CUI-2)
Item
Select the number of local laboratories used by the subject during the study.
integer
C0022877 (UMLS CUI [1,1])
C0205276 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
Code List
Select the number of local laboratories used by the subject during the study.
CL Item
One (1)
CL Item
Two (2)
CL Item
Three (3)
CL Item
Four (4)
CL Item
Five (5)
CL Item
Six (6)
Laboratory Name
Item
Laboratory Name
text
C3258037 (UMLS CUI [1])
Laboratory Address
Item
Laboratory Address
text
C1442065 (UMLS CUI [1,1])
C0022877 (UMLS CUI [1,2])
Laboratory ID
Item
Laboratory ID
text
C2986056 (UMLS CUI [1])
Item Group
Subject identification
C2348585 (UMLS CUI-1)
Subject number
Item
Subject number
text
C2348585 (UMLS CUI [1])
Item Group
Demography
C0011298 (UMLS CUI-1)
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Sex
text
C0079399 (UMLS CUI [1])
Code List
Sex
CL Item
Male (1)
CL Item
Female: Record chi|d—bearing potential (2)
CL Item
Female: Post-menopausal (3)
CL Item
Female: Sterile (of child—bearing age) (4)
CL Item
Female: Potentially able to bear children (5)
Item
Ethnicity
integer
C0015031 (UMLS CUI [1])
Code List
Ethnicity
CL Item
Hispanic or Latino (1)
CL Item
Not Hispanic or Latino (2)
Item
Geographic Ancestry
integer
C3841890 (UMLS CUI [1])
Code List
Geographic Ancestry
CL Item
African American/African Heritage (1)
CL Item
American Indian or Alaskan Native (2)
CL Item
Asian — Central/South Asian Heritage (3)
CL Item
Asian — East Asian Heritage (4)
CL Item
Asian — Japanese Heritage (5)
CL Item
Asian - South East Asian Heritage (6)
CL Item
Native Hawaiian or Other Pacific Islander (7)
CL Item
White - Arabic/ North African Heritage (8)
CL Item
White - White/Caucasian/European Heritage (9)
Item Group
Eligibility Question
C1516637 (UMLS CUI-1)
Did the subject meet all the entry criteria?
Item
Did the subject meet all the entry criteria?
boolean
C1516637 (UMLS CUI [1])
Item
If subject did not meet all the entry criteria, please select all boxes corresponding to violations of any inclusion/exclusion criteria
integer
C1516637 (UMLS CUI [1])
Code List
If subject did not meet all the entry criteria, please select all boxes corresponding to violations of any inclusion/exclusion criteria
CL Item
Inclucion criteria 1 (1)
CL Item
Inclucion criteria 2 (2)
CL Item
Inclucion criteria 3 (3)
CL Item
Inclucion criteria 4 (4)
CL Item
Inclucion criteria 5 (5)
CL Item
Inclucion criteria 6 (6)
CL Item
Inclucion criteria 7 (7)
CL Item
Inclucion criteria 8 (8)
CL Item
Inclucion criteria 9 (9)
CL Item
Exclusion Criteria 1 (10)
CL Item
Exclusion Criteria 2 (11)
CL Item
Exclusion Criteria 3 (12)
CL Item
Exclusion Criteria 4 (13)
CL Item
Exclusion Criteria 5 (14)
CL Item
Exclusion Criteria 6 (15)
CL Item
Exclusion Criteria 7 (16)
CL Item
Exclusion Criteria 8 (17)
CL Item
Exclusion Criteria 9 (18)
CL Item
Exclusion Criteria 10 (19)
CL Item
Exclusion Criteria 11 (20)
CL Item
Exclusion Criteria 12 (21)
CL Item
Exclusion Criteria 13 (22)
CL Item
Exclusion Criteria 14 (23)
CL Item
Exclusion Criteria 15 (24)
CL Item
Exclusion Criteria 16 (25)
CL Item
Exclusion Criteria 17 (26)
CL Item
Exclusion Criteria 18 (27)
Item Group
Disease Characteristics
C1705348 (UMLS CUI-1)
Item
Primary Tumour Type at Initial Diagnosis
integer
C0677930 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
C4071762 (UMLS CUI [1,3])
Code List
Primary Tumour Type at Initial Diagnosis
CL Item
Non-Small Cell Lung (1)
Date of Initial Diagnosis
Item
Date of Initial Diagnosis
date
C2316983 (UMLS CUI [1])
Item
Stage at Initial Diagnosis
integer
C1300072 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
C0205265 (UMLS CUI [1,3])
Code List
Stage at Initial Diagnosis
CL Item
I (1)
CL Item
II (2)
CL Item
IIIa (3)
CL Item
IIIb (4)
CL Item
IV (5)
Item
Histology at Initial Diagnosis
integer
C0019638 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
C0205265 (UMLS CUI [1,3])
Code List
Histology at Initial Diagnosis
CL Item
Adenocarcinoma (1)
CL Item
Bronchioloalveolar (2)
CL Item
Large cell carcinoma (3)
CL Item
Squamous (4)
CL Item
Unknown (5)
CL Item
Other, Specify (6)
Date of Last Progression
Item
Date of Last Progression
date
C0242656 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,3])
Date of Staging at Screening
Item
Date of Staging at Screening
date
C0011008 (UMLS CUI [1,1])
C0027646 (UMLS CUI [1,2])
C1710477 (UMLS CUI [2])
Item
Stage at Screening
integer
C1300072 (UMLS CUI [1,1])
C0220908 (UMLS CUI [1,2])
Code List
Stage at Screening
CL Item
IIIb (1)
CL Item
IV (2)
Lines of Therapy Completed at Screening
Item
Lines of Therapy Completed at Screening
integer
C1514463 (UMLS CUI [1])
Item Group
Metastatic Disease
C0027627 (UMLS CUI-1)
Did the subject have metastatic disease at screening?
Item
Did the subject have metastatic disease at screening?
boolean
C0027627 (UMLS CUI [1,1])
C0220908 (UMLS CUI [1,2])
If subject had metastatic disease at screening, complete date metastatic disease was first diagnosed
Item
If subject had metastatic disease at screening, complete date metastatic disease was first diagnosed
date
C0027627 (UMLS CUI [1,1])
C0220908 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item Group
Status at Screening
C0220908 (UMLS CUI-1)
C0449438 (UMLS CUI-2)
Did the subject receive prior chemo, immuno, hormonal or biologic therapies for the cancer under study?
Item
Did the subject receive prior chemo, immuno, hormonal or biologic therapies for the cancer under study?
boolean
C0392920 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2,1])
C0920425 (UMLS CUI [2,2])
C0332152 (UMLS CUI [2,3])
C1531518 (UMLS CUI [3,1])
C0920425 (UMLS CUI [3,2])
C0332152 (UMLS CUI [3,3])
C0021083 (UMLS CUI [4,1])
C0920425 (UMLS CUI [4,2])
C0332152 (UMLS CUI [4,3])
Did the subject receive prior radiotherapy for the cancer under study?
Item
Did the subject receive prior radiotherapy for the cancer under study?
boolean
C1522449 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
Has subject had prior surgery/ procedure?
Item
Has subject had prior surgery/ procedure?
boolean
C0744961 (UMLS CUI [1])
Were any concomitant medications taken by the subject prior to screening?
Item
Were any concomitant medications taken by the subject prior to screening?
boolean
C2347852 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0220908 (UMLS CUI [1,3])
Item Group
Anti-Cancer Therapy
C0920425 (UMLS CUI-1)
Sequence Number
Item
Sequence Number
integer
C2348184 (UMLS CUI [1])
Drug Name
Item
Drug Name
text
C0013227 (UMLS CUI [1])
Modified reported term
Item
Modified reported term
text
C2826302 (UMLS CUI [1])
GSK Drug synonym
Item
GSK Drug synonym
text
C0013227 (UMLS CUI [1,1])
C0871468 (UMLS CUI [1,2])
GSR Drug Collection code
Item
GSR Drug Collection code
text
C0013227 (UMLS CUI [1,1])
C1516698 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,3])
Failed coding
Item
Failed coding
text
C0805701 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
Regimen Sequence
Item
Regimen Sequence
integer
C1276413 (UMLS CUI [1,1])
C2348184 (UMLS CUI [1,2])
Item
Therapy Type
integer
C0332307 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Code List
Therapy Type
CL Item
Biologic Therapy (antibodies, cytokines) (1)
CL Item
Chemotherapy (cytotoxics, non-cytotoxics) (2)
CL Item
Hormonal Therapy (3)
CL Item
Immunotherapy (4)
Number of Cycles/Doses
Item
Number of Cycles/Doses
integer
C0178602 (UMLS CUI [1,1])
C0750480 (UMLS CUI [1,2])
Item
Units
integer
C1519795 (UMLS CUI [1])
Code List
Units
CL Item
Cycles (1)
CL Item
Doses (2)
Item
Intent
integer
C1283828 (UMLS CUI [1])
Code List
Intent
CL Item
Neo-adjuvant (1)
CL Item
Adjuva nt (2)
CL Item
Advanced or Metastatic (3)
Therapy Start Date
Item
Therapy Start Date
date
C1531783 (UMLS CUI [1])
Therapy Stop Date
Item
Therapy Stop Date
date
C1531784 (UMLS CUI [1])
Item
Best Response
integer
C2986560 (UMLS CUI [1])
Code List
Best Response
CL Item
Complete Response (1)
CL Item
Partial Response (2)
CL Item
Stable Disease (3)
CL Item
Prog ressive Disease (4)
CL Item
Unknown (5)
Duration of Response
Item
Duration of Response
durationDatetime
C0237585 (UMLS CUI [1])
Item Group
Anti-Cancer Therapy
C0920425 (UMLS CUI-1)
Sequence Number
Item
Sequence Number
integer
C2348184 (UMLS CUI [1])
Site
Item
Site
text
C2825164 (UMLS CUI [1])
Cumulative Dose
Item
Cumulative Dose
float
C2986497 (UMLS CUI [1])
Item
Units
integer
C1519795 (UMLS CUI [1])
Code List
Units
CL Item
Grays (1)
CL Item
Centigrays (2)
CL Item
x100 Rads (3)
Item
Intent
integer
C1283828 (UMLS CUI [1])
Code List
Intent
CL Item
Neo-adjuvant (1)
CL Item
Adjuvant (2)
CL Item
Advanced or Metastatic (3)
CL Item
Local/ Regional (4)
CL Item
Other (5)
Radiotherapy Start Date
Item
Radiotherapy Start Date
date
C0436382 (UMLS CUI [1])
Radiotherapy Stop Date
Item
Radiotherapy Stop Date
date
C1522449 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Best Response
integer
C2986560 (UMLS CUI [1])
Code List
Best Response
CL Item
Complete Response (1)
CL Item
Partial Response (2)
CL Item
Stable Disease (3)
CL Item
Progressive Disease (4)
CL Item
Not Evaluable (5)
Duration of Response
Item
Duration of Response
durationDatetime
C0237585 (UMLS CUI [1])
Item Group
Medical Conditions
C0012634 (UMLS CUI-1)
Sequence Number
Item
Sequence Number
integer
C2348184 (UMLS CUI [1])
Specific Condition
Item
Specific Condition
text
C0012634 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Modified Term
Item
Modified Term
text
C2826302 (UMLS CUI [1])
MedDRA Synonym
Item
MedDRA Synonym
text
C1140263 (UMLS CUI [1])
MedDRA lower level term code
Item
MedDRA lower level term code
text
C3898442 (UMLS CUI [1])
Failed coding
Item
Failed coding
text
C0805701 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
Item
NCI CTCAE v.3 Grade
integer
C3887242 (UMLS CUI [1])
Code List
NCI CTCAE v.3 Grade
CL Item
Grade 1 (1)
CL Item
Grade 2 (2)
CL Item
Grade 3 (3)
CL Item
Grade 4 (4)
CL Item
Not Applicable (5)
Item
Status
integer
C0449438 (UMLS CUI [1])
Code List
Status
CL Item
Current (1)
CL Item
Past (2)
Item
Classification
integer
C0008902 (UMLS CUI [1])
Code List
Classification
CL Item
Cancer related (1)
CL Item
Other (general) (2)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial